socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Friday, August 27, 2004

    Ambit Biosciences Raises $21M
    San Diego-based Ambit Biosciences announced that it has raised a Series C funding of $21.0M led by Roche Venture Fund. The company is developing biopharmaceuticals based on a proprietary high throughput human kinase assay drug screening panel. Ambit is also backed by Avalon Ventures, Forward Ventures, GIMV, and Perseus-Soros BioPharmaceutical Fund.
    posted on Friday, August 27, 2004 (Link to more information)

    Related companies:
    Ambit Biosciences

    Related stories:
    > Ambit Biosciences Gets $49M In Funding
    > Alacrity Biosciences Raises $8.45M In Debt
    > Anaptys Biosciences Raises $33.9M
    > Venture Investments Rise Nationally, Socal Investments Drop
    > Numira Biosciences Gets $2.5M in Series A

    RSS subscri be via emailEmail


    Previous news:

     Thursday, October 16, 2008
    Wednesday, October 15, 2008
    Tuesday, October 14, 2008
    Monday, October 13, 2008
    Friday, October 10, 2008